Central/abdominal obesity increases risk for which conditions?

• A. Cardiovascular disease and diabetes
• B. Asthma and allergies
• C. Kidney stones
• D. Joint disorders

Answer: (A)

Central/abdominal adiposity signals higher cardiometabolic risk because visceral fat is metabolically active and promotes insulin resistance, an inflammatory state, and atherogenic lipid changes. Fat stored around the organs releases free fatty acids and inflammatory cytokines into the portal circulation, driving hepatic glucose production and contributing to high triglycerides and low HDL, all of which elevate the risk of type 2 diabetes and cardiovascular disease. This is why central obesity is a stronger predictor of these problems than overall body weight alone, and why waist measurements help assess risk.

The other conditions listed are not driven primarily by where fat is stored. Asthma and allergies relate more to airway inflammation and immune responses; kidney stones form from urinary chemistry and mineral balance; joint disorders like osteoarthritis are more about mechanical stress and overall wear, though obesity can worsen them. The link between central obesity and these conditions is much weaker than with cardiovascular disease and diabetes.